Accendra Health (ACH) EBITDA (2009 - 2026)

Accendra Health (ACH) has 18 years of EBITDA data on file, last reported at $46.0 million in Q1 2026.

• EBITDA for Q1 2026 came in at $46.0 million, down 10.61% year-over-year; the trailing twelve-month figure through Mar 2026 was $100.0 million (up 226.78% YoY), and the FY2025 annual result was $105.4 million, up 215.93% from the prior year.
• EBITDA rose to $46.0 million in Q1 2026 per ACH's latest filing, from $3.6 million in the prior quarter.
• Over five years, EBITDA peaked at $88.7 million in Q4 2023 and troughed at -$241.2 million in Q4 2024.
• A 5-year average of $18.1 million and a median of $46.0 million in 2026 frame the typical range for EBITDA.
• The sharpest annual moves came in 2024 and 2025: EBITDA tumbled 371.84% in 2024, then soared 430.88% in 2025.
• A 5-year view of EBITDA shows it stood at -$53.5 million in 2022, then soared by 265.94% to $88.7 million in 2023, then sank by 371.84% to -$241.2 million in 2024, then surged by 101.5% to $3.6 million in 2025, then surged by 1174.98% to $46.0 million in 2026.
• Business Quant data shows ACH's EBITDA at $46.0 million in Q1 2026, $3.6 million in Q4 2025, and $58.2 million in Q3 2025.